Curis | CRIS - L'Utile Ante Imposte





L'Utile Ante Imposte Cambiamento Data
Alaunos Therapeutics USD -7.84M 633K 2023-12
Amgen USD 3.92B 2.35B 2025-09
AstraZeneca USD 3.24B 117M 2025-09
Bayer EUR -1.16B 735M 2025-09
Bristol-Myers Squibb USD 3.11B 1.34B 2025-09
CSL USD 2.61B 1.21B 2025-12
Curis USD 19.36M 33.34M 2025-12
Eli Lilly USD 7.23B 456M 2025-09
Exelixis USD 252.69M 275K 2025-12
Gilead Sciences USD 3.64B 1.21B 2025-09
GlaxoSmithKline GBP 1.23B 1.23B 2025-12
Incyte USD 389.94M 92.37M 2025-12
Merck USD 6.74B 22M 2025-09
Novartis USD 4.64B 445M 2025-12
Pfizer USD 3.33B 290M 2025-09
Roche Holding CHF 4.79B 3.01B 2025-06
Sanofi EUR -1.16B 5.5B 2025-12
Takeda JPY 133.86B 105.69B 2025-12
TG Therapeutics USD 45.09M 19.18M 2025-12
Verastem USD -32.92M 944K 2025-12
Xoma USD 15.98M 24.58M 2024-06